AGA Guideline Defines Role of Biomarkers in Ulcerative Colit

In many cases, biomarkers should be considered before pursuing endoscopy or treatment adjustments.

Related Keywords

New York , United States , American , Siddharth Singh , Pfizer , University Of California San Diego , Langone Health Inflammatory Bowel Disease Center , American Gastroenterological Association , California San Diego , Inflammatory Bowel Disease Center , Ulcerative Colitis , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Biomarker , Iological Marker , Clinical Guidelines , Guidelines , Endoscopy , Remission , Colitis , C Reactive Protein , , Immunosuppressive Therapy , Immunosuppressive Agents , Immunosuppressive Drugs , Rug Immunosuppressive , Physician Patient Decision Making , Patient Counseling , Rovider Patient Communication , Linici ,